Chia review reports lower blood pressure, with limited certainty
An umbrella review found shifts in several measured health markers, but results were not uniformly favorable and most evidence had moderate or low certainty.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Chia supplementation was associated with lower blood pressure, several blood lipid measures, waist circumference and an inflammation marker in pooled trial evidence. HDL cholesterol also fell, so the lipid findings were not uniformly favorable. These results concern measured markers and body size, rather than demonstrated reductions in illness or cardiovascular events.
Most outcomes had moderate or low evidence certainty. The abstract does not identify comparison conditions, doses or follow-up lengths, limiting interpretation of what was tested and for whom.
Reviews of existing trials
An umbrella review brings together existing reviews, rather than enrolling a new group of participants. Here, the researchers summarized randomized-trial reviews covering blood pressure, blood lipids, inflammation and body measurements.
Understanding the effect scale
The reported effect sizes use Hedges' g, a standardized scale. They are not percentages or direct changes in blood-pressure units, and the abstract does not establish how noticeable the changes would be to participants.
The original publication
A Critical Review of the Health Benefits Associated with Chia Seeds (Salvia Hispanica L.).
Al-Younis ZK, Al-Shawi SG, Kareem AK et al.
Plant Foods Hum Nutr · 2025
- PubMed ID
- 41076614
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.